Citius Pharmaceuticals, Inc. (CTXR)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
0. 46
0
0%
$
12.63M Market Cap
- P/E Ratio
- Div Yield
141,000 Volume
0.03 Eps
$ 0.46
Previous Close 
Want to track CTXR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Citius Pharmaceuticals, Inc. (CTXR) Statistics
Valuation metrics
Market Cap 12.63M
Enterprise value 2.8M
Trailing P/E (ttm) -0.22
Forward P/E 0.31
PEG ratio -0
Price/Sales (ttm) 1.78
Price/Book (mrq) 0.18
Enterprise Value/Revenue 0.39
Enterprise Value/EBITDA -0.05
Overview
Shares outstanding 22.38M
Float 21.88M
Shares short 3.91M
% Held by insiders 0.02%
% Held by institutions 0.08%
Average volume (10 days) 178.56K
Average volume (90 days) 527.95K
Price summary
52-Week low 0.45
52-Week high 2.19
Beta 1.38
50-Day moving average 0.55
200-Day moving average 0.62
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 26 Nov 2024
Financials
Fiscal year
Fiscal year ends 30 Sep 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -6.51%
Operating margin -8.64%
Operational effectiveness
Return on assets -0.33%
Return on equity -0.67%
Income Statement
Revenue (ttm) 3.94M
Revenue per share (ttm) 0.27
Quarterly revenue growth (yoy) -
Gross profit (ttm) 3.15M
EBITDA -36.36M
Net income to common (ttm) -35.89M
Diluted EPS (ttm) -1.77
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 7.72M
Total cash per share (mrq) 0.65
Total debt (mrq) 1.83M
Total Debt/Equity (mrq) 0.11
Current ratio (mrq) 0.84%
Book value per share (mrq) 2.9
Cash Flow
Cash flow statement -34.84M
Levered free cash flow (LFCF) -40.53M
2026 © Marketlog. All Rights Reserved.
